Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer | Zendy

Olivia Pagani | Zendy; Meredith M. Regan | Zendy; Barbara Walley | Zendy; Gini F. Fleming | Zendy; Marco Colleoni | Zendy; István Láng | Zendy; Henry Gómez | Zendy; Carlo Tondini | Zendy; Harold J. Burstein | Zendy; Edith A. Perez | Zendy; Eva Ciruelos | Zendy; Vered Stearns | Zendy; Hervé Bonnefoi | Zendy; Silvana Martino | Zendy; Charles E. Geyer | Zendy; Graziella Pinotti | Zendy; Fabio Puglisi | Zendy; Diana Crivellari | Zendy; Thomas Ruhstaller | Zendy; Eric P. Winer | Zendy; Manuela Rabaglio | Zendy; Rudolf Maibach | Zendy; Barbara Ruepp | Zendy; Anita GiobbieHurder | Zendy; Karen N. Price | Zendy; Jürg Bernhard | Zendy; Weixiu Luo | Zendy; Karin Ribi | Zendy; Giuseppe Viale | Zendy; Alan S. Coates | Zendy; Richard D. Gelber | Zendy; Aron Goldhirsch | Zendy; Prudence A. Francis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

Author(s) -

Olivia Pagani,

Meredith M. Regan,

Barbara Walley,

Gini F. Fleming,

Marco Colleoni,

István Láng,

Henry Gómez,

Carlo Tondini,

Harold J. Burstein,

Edith A. Perez,

Eva Ciruelos,

Vered Stearns,

Hervé Bonnefoi,

Silvana Martino,

Charles E. Geyer,

Graziella Pinotti,

Fabio Puglisi,

Diana Crivellari,

Thomas Ruhstaller,

Eric P. Winer,

Manuela Rabaglio,

Rudolf Maibach,

Barbara Ruepp,

Anita GiobbieHurder,

Karen N. Price,

Jürg Bernhard,

Weixiu Luo,

Karin Ribi,

Giuseppe Viale,

Alan S. Coates,

Richard D. Gelber,

Aron Goldhirsch,

Prudence A. Francis

Publication year - 2014

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1404037

Subject(s) - medicine , exemestane , adjuvant , breast cancer , oncology , gynecology , ovarian cancer , aromatase , cancer

Adjuvant therapy with an aromatase inhibitor improves outcomes, as compared with tamoxifen, in postmenopausal women with hormone-receptor-positive breast cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore